aod9604 peptide aod9604 what is it AOD-9604 (5MG) AOD-9604 Vial (10mg) | High-Purity
Description
If the abovementioned is occurring, it could mean that IGF-1 administration could also lower glucose levels by suppressing hepatic gluconeogenesis, as well as improving insulin signalling in this organ, leading to IGFBP-1 suppression and overall improvement of the IGF-1/GH/insulin axis
Male, 18-week-old C57BL/6J mice, maintained on a 60% high-fat diet (HFD
Accessing this peptide requires a compounding pharmacy with the expertise to prepare it safely and accurately
Research Use Notice: This product is intended strictly for research and laboratory use only
